十大电竞外围

₹163.3952 (-0.24%) Nav, as on 09-09-2022
Previous Nav
₹ 163.7812
Net Change on 09-09-2022
₹-0.39
十大电竞(广州)最新版登录正规 Rating
Unrated
Category
Equity - Sectoral Fund - Pharma & Health Care
Assets (Cr.)
₹ 713.11
Expense Ratio
1.42%
(As on Jul 31, 2022)

Fund Overview Growth | Direct Plan

Fund House
UTI Mutual Fund
Launch Date
01-Jan-2013
Benchmark
NIFTY 50 - TRI
Minimum Investment (₹)
5,000
Minimum Addl Investment (₹)
1,000
Exit Load (%)
1% on or before 30D, Nil after 30D
Minimum SIP Investment (₹)
500
Minimum STP Investment (₹)
100
Minimum SWP Investment (₹)
500
52 Week Low Nav (₹)
148.55
52 Week Low Nav Date
17-Jun-2022
52 Week High Nav (₹)
188.18
52 Week High Nav Date
04-Oct-2021

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name	1-Month Return (%)	3-Month Return (%)	1-Year Return (%)	3-Year Return (%)	5-Year Return (%)	Since Inception
UTI Healthcare Fund - Direct Plan - Growth Option	0.28	4.82	-10.98	24.33	14.22	13.55
NIFTY 50 - TRI	N/A	N/A	N/A	N/A	N/A	N/A
S&P BSE Health Care	-0.41	4.84	-12.66	21.15	12.00	14.23
S&P BSE Health Care - TRI	-0.22	5.25	-12.06	21.96	12.77	13.71

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name	Launch Date	1-Year Return (%)	3-Year Return (%)	5-Year Return (%)	Expense Ratio (%)	Assets (Cr.)
UTI Healthcare Fund - Direct Plan - Growth Option	Jan 01, 2013	-10.98	24.33	14.22	1.42	713.11
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth	Jan 01, 2013	-10.06	25.85	18.80	1.06	4,587.75
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH	Jan 01, 2013	-6.70	25.82	13.75	1.07	1,675.44
Tata India Pharma & Healthcare Fund-Direct Plan-Growth	Dec 28, 2015	-7.84	24.29	17.19	0.99	519.10

Fund Holdings as on 31-August-2022

Company % Assets
EQ - SUN PHARMACEUTICALS INDUSTRIES
11.37
EQ - DR REDDYS LABORATORIES LTD.
8.82
EQ - CIPLA LTD.
8.20
EQ - APOLLO HOSPITALS ENTERPRISE LT
5.47
EQ - FORTIS HEALTHCARE LTD.
5.02
EQ - AUROBINDO PHARMA LTD.
4.46
EQ - DIVIS LABORATORIES LTD.
4.37
EQ - AJANTA PHARMA LTD.
4.02
EQ - ERIS LIFESCIENCES LTD
3.63
EQ - IPCA LABORATORIES LTD.
3.57
EQ - ZYDUS LIFESCIENCES LTD
3.40
EQ - KRISHNA INSTITUTE OF MEDI SCIE
3.10
EQ - TORRENT PHARMACEUTICALS LTD.
2.91
EQ - BIOCON LTD.
2.59
EQ - SUVEN PHARMACEUTICALS LTD
2.47
EQ - GLAND PHARMA LTD.
2.41
EQ - ALKEM LABORATORIES LTD
2.35
EQ - LUPIN LTD.
2.07
EQ - ABBOTT INDIA LTD.
1.96
EQ - POLY MEDICURE LTD
1.92
EQ - J.B.CHEMICALS & PHARMACEUTICAL
1.89
NET CURRENT ASSETS
1.83
EQ - RAINBOW CHILDRENS MEDICARE LTD
1.73
EQ - PROCTOR & GAMBLE HEALTH LTD
1.63
EQ - ALEMBIC PHARMACEUTICALS
1.47
EQ - PFIZER LIMITED
1.38
EQ - AMI ORGANICS LTD
1.35
EQ - METROPOLIS HEALTHCARE LTD
1.25
EQ - SEQUENT SCIENTIFIC LTD
0.99
EQ - INDOCO REMEDIES LTD.
0.67
EQ - NARAYANA HRUDAYALAYA LTD
0.65
EQ - WINDLAS BIOTEC LTD
0.56
INDIAN BANK STD - MARGIN
0.28
T BILL RESERVE BANK OF INDIA
0.17
CLEARING CORPORATION OF INDIA LTD. STD - MARGIN
0.02

Sector Holding%
Pharmaceuticals & Drugs
78.57
Hospital & Healthcare Services
17.21
Medical Equipment/Supplies/Accessories
1.92
Miscellaneous
1.83

Fund Manager

V. Srivatsa

Education: B.Com., ICWA, ACA, PGDM
Experience: 5 Yeras
Basic Details: He has 3 years of experience in the Equity Securities Research handling variety of sectors. Last two years in the fund management as fund manager for offshore funds. He is looking after fund management of Hybrid Schemes as an adhoc arrangement and reports to Head of Fixed Income.
Funds Managed:
UTI Core Equity Fund
UTI Equity Savings Fund
UTI Healthcare Fund
UTI Healthcare Fund
UTI Hybrid Equity Fund
UTI-Retirement Benefit Pension Fund

Kamal Gada

Education: B.Com, CA, CS, CFA
Experience:
Basic Details:
Funds Managed:
UTI Healthcare Fund
UTI Healthcare Fund
UTI Small Cap Fund
UTI Small Cap Fund

Holding Type Holding %
Cash
1.83
Deposits
0.30
Equity
97.68
SOV
0.17

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund . It was launched on 01-Jan-2013 and currently has an AUM of ₹713.11 crore. UTI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of UTI Healthcare Fund ended down ₹-0.39 (-0.24%) yesterday to ₹163.3952 .

Among its top 3 holdings the fund has exposure to EQ - SUN PHARMACEUTICALS INDUSTRIES, and

The UTI Healthcare Fund is managed by V. Srivatsa and Kamal Gada.

Fund House Contact

Address:

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

Phone Number: +91 (22) 66786666

Email Address: service@uti.co.in

Fax Number: +91 (22) 66786503,56786578

Website: www.utimf.com

Financial Health Checkup

Money Simplified Videos

Infographics